Harbor Health Care ETF MEDI
Set alert
35.20 USD -0.08 -0.24%
As of Oct 30, 1:17 PM ET
35.20 Day range 35.76
27.78 52-week range 35.60
- YTD
- +11.93%
- 1 year
- +17.03%
- Open
- 35.73
- Prev close
- 35.29
- Mkt cap
- 23.59M
- Vol
- 5.06K
- Avg vol
- 4.60K
- EPS
- 1.20
- P/E
- 29.45
- Div yield
- 0.00%
More statistics
- Low
- 35.20
- High
- 35.76
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 26.44
- 200-d avg
- 26.40
3M chart
Signals (10)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 38.53
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 26.44
- 200-day average
- 26.40
About Harbor Health Care ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (“health care companies”). It is non-diversified.
News
- Why Is Ascendis Pharma Stock Trading Lower on Tuesday?
- Why Is Legend Biotech Stock Falling Thursday?
- Why Is Legend Biotech Stock Falling Thursday?
- Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
- Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
- Harbor Health Care ETF Q4 2025 Portfolio Review
- Harbor Health Care ETF Q4 2025 Commentary
- Why Your Pneumonia Shot Is About To Get A Massive Upgrade
- Harbor Health Care ETF Q3 2025 Commentary
- Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs
Your note
Sign in to keep a note on MEDI — it syncs with the Stock Master app.